Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC639719414;19415;19416 chr2:178728737;178728736;178728735chr2:179593464;179593463;179593462
N2AB608018463;18464;18465 chr2:178728737;178728736;178728735chr2:179593464;179593463;179593462
N2A515315682;15683;15684 chr2:178728737;178728736;178728735chr2:179593464;179593463;179593462
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACG
  • RefSeq wild type template codon: TGC
  • Domain: Ig-48
  • Domain position: 13
  • Structural Position: 18
  • Q(SASA): 0.5529
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/M rs199564845 0.039 1.0 D 0.633 0.422 None gnomAD-2.1.1 2.82E-05 None None None None N None 1.29349E-04 8.74E-05 None 0 0 None 0 None 0 1.78E-05 0
T/M rs199564845 0.039 1.0 D 0.633 0.422 None gnomAD-3.1.2 5.92E-05 None None None None N None 4.83E-05 1.96489E-04 0 0 0 None 0 0 5.88E-05 0 0
T/M rs199564845 0.039 1.0 D 0.633 0.422 None gnomAD-4.0.0 2.79825E-05 None None None None N None 9.35404E-05 8.35478E-05 None 0 0 None 1.56392E-05 0 2.63781E-05 0 1.60679E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.2264 likely_benign 0.2155 benign -0.547 Destabilizing 0.981 D 0.544 neutral N 0.509334536 None None N
T/C 0.8545 likely_pathogenic 0.7967 pathogenic -0.364 Destabilizing 1.0 D 0.622 neutral None None None None N
T/D 0.8184 likely_pathogenic 0.8555 pathogenic 0.17 Stabilizing 0.999 D 0.607 neutral None None None None N
T/E 0.6583 likely_pathogenic 0.7182 pathogenic 0.147 Stabilizing 0.999 D 0.602 neutral None None None None N
T/F 0.6546 likely_pathogenic 0.7038 pathogenic -0.702 Destabilizing 1.0 D 0.737 prob.delet. None None None None N
T/G 0.6124 likely_pathogenic 0.627 pathogenic -0.772 Destabilizing 0.997 D 0.615 neutral None None None None N
T/H 0.7021 likely_pathogenic 0.714 pathogenic -1.005 Destabilizing 1.0 D 0.712 prob.delet. None None None None N
T/I 0.5262 ambiguous 0.623 pathogenic -0.055 Destabilizing 1.0 D 0.636 neutral None None None None N
T/K 0.4007 ambiguous 0.4969 ambiguous -0.543 Destabilizing 1.0 D 0.609 neutral N 0.521031609 None None N
T/L 0.2086 likely_benign 0.2564 benign -0.055 Destabilizing 0.998 D 0.579 neutral None None None None N
T/M 0.1471 likely_benign 0.1773 benign 0.061 Stabilizing 1.0 D 0.633 neutral D 0.534155622 None None N
T/N 0.434 ambiguous 0.4588 ambiguous -0.411 Destabilizing 0.999 D 0.645 neutral None None None None N
T/P 0.4019 ambiguous 0.3651 ambiguous -0.187 Destabilizing 0.999 D 0.62 neutral D 0.526882933 None None N
T/Q 0.4952 ambiguous 0.5439 ambiguous -0.564 Destabilizing 1.0 D 0.635 neutral None None None None N
T/R 0.3296 likely_benign 0.3843 ambiguous -0.305 Destabilizing 1.0 D 0.615 neutral D 0.523071837 None None N
T/S 0.3 likely_benign 0.2849 benign -0.687 Destabilizing 0.905 D 0.376 neutral D 0.528880302 None None N
T/V 0.3782 ambiguous 0.4429 ambiguous -0.187 Destabilizing 0.998 D 0.597 neutral None None None None N
T/W 0.8839 likely_pathogenic 0.8931 pathogenic -0.67 Destabilizing 1.0 D 0.721 prob.delet. None None None None N
T/Y 0.7705 likely_pathogenic 0.7851 pathogenic -0.422 Destabilizing 1.0 D 0.728 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.